# Fedex Corp: financial statements, quarterly

FDX · NYSE · CIK 1048911 · [Industrials](/sectors/industrials.md) · fiscal year ends May 31

Pages: [Overview](/companies/fdx.md) · [Financials](/companies/fdx/financials.md) · [Filings](/companies/fdx/filings.md) · [Insiders](/companies/fdx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fdx/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-08-31) | Q2 FY2024 (2023-11-30) | Q3 FY2024 (2024-02-29) | Q4 FY2024 (2024-05-31) | Q1 FY2025 (2024-08-31) | Q2 FY2025 (2024-11-30) | Q3 FY2025 (2025-02-28) | Q4 FY2025 (2025-05-31) | Q1 FY2026 (2025-08-31) | Q2 FY2026 (2025-11-30) | Q3 FY2026 (2026-02-28) | Q4 FY2026 (2026-05-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [21.7](/filings/0000950170-24-108107.md) | [22.2](/filings/0000950170-24-138460.md) | [21.7](/filings/0000950170-25-042672.md) | [22.1 d](/filings/0001048911-26-000105.md) | [21.6](/filings/0001048911-25-000044.md) | [22.0](/filings/0001048911-25-000078.md) | [22.2](/filings/0001048911-26-000011.md) | [22.2 d](/filings/0001048911-26-000105.md) | [22.2](/filings/0001048911-25-000044.md) | [23.5](/filings/0001048911-25-000078.md) | [24.0](/filings/0001048911-26-000011.md) | [25.0 d](/filings/0001048911-26-000105.md) |
| Cost of revenue | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $bn | [1.5](/filings/0000950170-24-108107.md) | [1.3](/filings/0000950170-24-138460.md) | [1.2](/filings/0000950170-25-042672.md) | [1.6 d](/filings/0001048911-26-000105.md) | [1.1](/filings/0001048911-25-000044.md) | [1.1](/filings/0001048911-25-000078.md) | [1.3](/filings/0001048911-26-000011.md) | [1.8 d](/filings/0001048911-26-000105.md) | [1.2](/filings/0001048911-25-000044.md) | [1.4](/filings/0001048911-25-000078.md) | [1.3](/filings/0001048911-26-000011.md) | [1.6 d](/filings/0001048911-26-000105.md) |
| Income tax | $bn | [0.3](/filings/0000950170-24-108107.md) | [0.3](/filings/0000950170-24-138460.md) | [0.3](/filings/0000950170-25-042672.md) | [0.6 d](/filings/0001048911-26-000105.md) | [0.3](/filings/0001048911-25-000044.md) | [0.2](/filings/0001048911-25-000078.md) | [0.3](/filings/0001048911-26-000011.md) | [0.6 d](/filings/0001048911-26-000105.md) | [0.3](/filings/0001048911-25-000044.md) | [0.3](/filings/0001048911-25-000078.md) | [0.2](/filings/0001048911-26-000011.md) | [0.5 d](/filings/0001048911-26-000105.md) |
| Net income | $bn | [1.1](/filings/0000950170-24-108107.md) | [0.9](/filings/0000950170-24-138460.md) | [0.9](/filings/0000950170-25-042672.md) | [1.5 d](/filings/0001048911-26-000105.md) | [0.8](/filings/0001048911-25-000044.md) | [0.7](/filings/0001048911-25-000078.md) | [0.9](/filings/0001048911-26-000011.md) | [1.6 d](/filings/0001048911-26-000105.md) | [0.8](/filings/0001048911-25-000044.md) | [1.0](/filings/0001048911-25-000078.md) | [1.1](/filings/0001048911-26-000011.md) | [1.6 d](/filings/0001048911-26-000105.md) |
| Diluted EPS | $ per share | [4.23](/filings/0000950170-24-108107.md) | [3.55](/filings/0000950170-24-138460.md) | [3.51](/filings/0000950170-25-042672.md) | not reported | [3.21](/filings/0001048911-25-000044.md) | [3.03](/filings/0001048911-25-000078.md) | [3.76](/filings/0001048911-26-000011.md) | not reported | [3.46](/filings/0001048911-25-000044.md) | [4.04](/filings/0001048911-25-000078.md) | [4.41](/filings/0001048911-26-000011.md) | not reported |
| Basic EPS | $ per share | [4.28](/filings/0000950170-24-108107.md) | [3.59](/filings/0000950170-24-138460.md) | [3.55](/filings/0000950170-25-042672.md) | not reported | [3.24](/filings/0001048911-25-000044.md) | [3.06](/filings/0001048911-25-000078.md) | [3.79](/filings/0001048911-26-000011.md) | not reported | [3.48](/filings/0001048911-25-000044.md) | [4.07](/filings/0001048911-25-000078.md) | [4.46](/filings/0001048911-26-000011.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-08-31) | Q2 FY2024 (2023-11-30) | Q3 FY2024 (2024-02-29) | FY2024 (2024-05-31) | Q1 FY2025 (2024-08-31) | Q2 FY2025 (2024-11-30) | Q3 FY2025 (2025-02-28) | FY2025 (2025-05-31) | Q1 FY2026 (2025-08-31) | Q2 FY2026 (2025-11-30) | Q3 FY2026 (2026-02-28) | FY2026 (2026-05-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [7.1](/filings/0000950170-23-048994.md) | [6.7](/filings/0000950170-23-071495.md) | [5.6](/filings/0000950170-24-034709.md) | [6.5](/filings/0001048911-25-000011.md) | [5.9](/filings/0000950170-24-108107.md) | [5.0](/filings/0000950170-24-138460.md) | [5.1](/filings/0001048911-26-000011.md) | [5.5](/filings/0001048911-26-000105.md) | [6.2](/filings/0001048911-25-000044.md) | [6.6](/filings/0001048911-25-000078.md) | [8.0](/filings/0001048911-26-000011.md) | [13.3](/filings/0001048911-26-000105.md) |
| Current assets | $bn | [18.9](/filings/0000950170-23-048994.md) | [19.1](/filings/0000950170-23-071495.md) | [17.4](/filings/0000950170-24-034709.md) | [18.2](/filings/0001048911-25-000011.md) | [18.1](/filings/0000950170-24-108107.md) | [17.7](/filings/0000950170-24-138460.md) | [17.2](/filings/0000950170-25-042672.md) | [18.4](/filings/0001048911-26-000105.md) | [19.3](/filings/0001048911-25-000044.md) | [20.7](/filings/0001048911-25-000078.md) | [25.5](/filings/0001048911-26-000011.md) | [27.9](/filings/0001048911-26-000105.md) |
| Total assets | $bn | [87.6](/filings/0000950170-23-048994.md) | [88.1](/filings/0000950170-23-071495.md) | [86.1](/filings/0000950170-24-034709.md) | [87.0](/filings/0001048911-26-000105.md) | [86.7](/filings/0000950170-24-108107.md) | [85.5](/filings/0000950170-24-138460.md) | [85.0](/filings/0000950170-25-042672.md) | [87.6](/filings/0001048911-26-000105.md) | [88.4](/filings/0001048911-25-000044.md) | [89.2](/filings/0001048911-25-000078.md) | [94.7](/filings/0001048911-26-000011.md) | [98.9](/filings/0001048911-26-000105.md) |
| Current liabilities | $bn | [13.8](/filings/0000950170-23-048994.md) | [14.2](/filings/0000950170-23-071495.md) | [13.3](/filings/0000950170-24-034709.md) | [13.4](/filings/0001048911-25-000011.md) | [14.1](/filings/0000950170-24-108107.md) | [14.4](/filings/0000950170-24-138460.md) | [13.9](/filings/0000950170-25-042672.md) | [15.4](/filings/0001048911-26-000105.md) | [15.5](/filings/0001048911-25-000044.md) | [16.2](/filings/0001048911-25-000078.md) | [17.3](/filings/0001048911-26-000011.md) | [18.9](/filings/0001048911-26-000105.md) |
| Long-term debt | $bn | not reported | not reported | not reported | [19.8](/filings/0000950170-24-083577.md) | not reported | not reported | not reported | [19.2](/filings/0001048911-26-000105.md) | not reported | not reported | not reported | [23.3](/filings/0001048911-26-000105.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001048911-26-000105.md) | not reported | not reported | [0.0](/filings/0001048911-26-000011.md) | [0.7](/filings/0001048911-26-000105.md) |
| Shareholders' equity | $bn | [26.5](/filings/0000950170-24-108107.md) | [26.8](/filings/0000950170-24-138460.md) | [26.4](/filings/0000950170-25-042672.md) | [27.6](/filings/0001048911-26-000105.md) | [27.2](/filings/0001048911-25-000044.md) | [26.5](/filings/0001048911-25-000078.md) | [26.7](/filings/0001048911-26-000011.md) | [28.1](/filings/0001048911-26-000105.md) | [27.8](/filings/0001048911-25-000044.md) | [28.1](/filings/0001048911-25-000078.md) | [29.8](/filings/0001048911-26-000011.md) | [31.6](/filings/0001048911-26-000105.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebt, us-gaap:LongTermDebtNoncurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings, us-gaap:CommercialPaper
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-08-31) | Q2 FY2024 (2023-11-30) | Q3 FY2024 (2024-02-29) | Q4 FY2024 (2024-05-31) | Q1 FY2025 (2024-08-31) | Q2 FY2025 (2024-11-30) | Q3 FY2025 (2025-02-28) | Q4 FY2025 (2025-05-31) | Q1 FY2026 (2025-08-31) | Q2 FY2026 (2025-11-30) | Q3 FY2026 (2026-02-28) | Q4 FY2026 (2026-05-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [2,230](/filings/0000950170-24-108107.md) | [1,774 d](/filings/0000950170-24-138460.md) | [1,610 d](/filings/0000950170-25-042672.md) | [2,698 d](/filings/0001048911-26-000105.md) | [1,187](/filings/0001048911-25-000044.md) | [1,318 d](/filings/0001048911-25-000078.md) | [2,012 d](/filings/0001048911-26-000011.md) | [2,519 d](/filings/0001048911-26-000105.md) | [1,716](/filings/0001048911-25-000044.md) | [1,951 d](/filings/0001048911-25-000078.md) | [1,993 d](/filings/0001048911-26-000011.md) | [3,265 d](/filings/0001048911-26-000105.md) |
| Capital expenditure | $m | [1,290](/filings/0000950170-24-108107.md) | [1,305 d](/filings/0000950170-24-138460.md) | [1,379 d](/filings/0000950170-25-042672.md) | [1,202 d](/filings/0001048911-26-000105.md) | [767](/filings/0001048911-25-000044.md) | [818 d](/filings/0001048911-25-000078.md) | [997 d](/filings/0001048911-26-000011.md) | [1,473 d](/filings/0001048911-26-000105.md) | [623](/filings/0001048911-25-000044.md) | [757 d](/filings/0001048911-25-000078.md) | [955 d](/filings/0001048911-26-000011.md) | [1,474 d](/filings/0001048911-26-000105.md) |
| Dividends paid | $m | [318](/filings/0000950170-24-108107.md) | [317 d](/filings/0000950170-24-138460.md) | [314 d](/filings/0000950170-25-042672.md) | [310 d](/filings/0001048911-26-000105.md) | [339](/filings/0001048911-25-000044.md) | [337 d](/filings/0001048911-25-000078.md) | [332 d](/filings/0001048911-26-000011.md) | [331 d](/filings/0001048911-26-000105.md) | [345](/filings/0001048911-25-000044.md) | [342 d](/filings/0001048911-25-000078.md) | [341 d](/filings/0001048911-26-000011.md) | [346 d](/filings/0001048911-26-000105.md) |
| Share repurchases | $m | [500](/filings/0000950170-24-108107.md) | [500 d](/filings/0000950170-24-138460.md) | [1,000 d](/filings/0000950170-25-042672.md) | [500 d](/filings/0001048911-26-000105.md) | [1,000](/filings/0001048911-25-000044.md) | [1,020 d](/filings/0001048911-25-000078.md) | [497 d](/filings/0001048911-26-000011.md) | [500 d](/filings/0001048911-26-000105.md) | [500](/filings/0001048911-25-000044.md) | [296 d](/filings/0001048911-25-000078.md) | [0.0 d](/filings/0001048911-26-000011.md) | [0.0 d](/filings/0001048911-26-000105.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-08-31) | Q2 FY2023 (2022-11-30) | Q3 FY2023 (2023-02-28) | Q1 FY2024 (2023-08-31) | Q2 FY2024 (2023-11-30) | Q3 FY2024 (2024-02-29) | Q1 FY2025 (2024-08-31) | Q2 FY2025 (2024-11-30) | Q3 FY2025 (2025-02-28) | Q1 FY2026 (2025-08-31) | Q2 FY2026 (2025-11-30) | Q3 FY2026 (2026-02-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [262](/filings/0000950170-23-048994.md) | [256](/filings/0000950170-23-071495.md) | [253](/filings/0000950170-24-034709.md) | [254](/filings/0000950170-24-108107.md) | [253](/filings/0000950170-24-138460.md) | [250](/filings/0000950170-25-042672.md) | [247](/filings/0001048911-25-000044.md) | [244](/filings/0001048911-25-000078.md) | [242](/filings/0001048911-26-000011.md) | [238](/filings/0001048911-25-000044.md) | [236](/filings/0001048911-25-000078.md) | [239](/filings/0001048911-26-000011.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 236,581,188 at 2026-07-16, from the cover of the [10-K filed 2026-07-20](/filings/0001048911-26-000105.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.